We further evaluated the effect of USP35 silence on the chemosensitivity of lung cancer cells to DDP and PTX, and found that USP35‐deficient lung cancer cells are more sensitive to DDP and PTX chemotherapy. The gene discussed is USP35; the disease is lung cancer.